Q32 Bio (QTTB) Net Cash Flow (QoQ) (2017 - 2026)
Q32 Bio (QTTB) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 430.73% |
| Dec 31, 2025 | 87.19% |
| Sep 30, 2025 | 45.61% |
| Jun 30, 2025 | 14.67% |
| Mar 31, 2025 | -12.32% |
| Dec 31, 2024 | -29.48% |
| Sep 30, 2024 | 51.91% |
| Jun 30, 2024 | -121.02% |
| Mar 31, 2024 | 897.93% |
| Dec 31, 2023 | -165.67% |
| Sep 30, 2023 | 242.72% |
| Jun 30, 2023 | 9.09% |
| Mar 31, 2023 | -36.07% |
| Dec 31, 2022 | 93.10% |
| Sep 30, 2022 | -84.21% |
| Jun 30, 2022 | -152.30% |
| Mar 31, 2022 | 943.44% |
| Dec 31, 2021 | 164.60% |
| Sep 30, 2021 | -272.18% |
| Jun 30, 2021 | 110.53% |